Because KDM2A has the activity to reduce rRNA transcription and proliferation of breast cancer cells [12], we previously proposed that the reduction of rRNA transcription by KDM2A specifically in cancer cells may be applied to the treatment of breast cancers [21]. Here, KDM2A is linked to breast carcinoma.